Analysts at Roth Capital decreased their FY2029 EPS estimates for shares of Zevra Therapeutics in a report issued on Tuesday, ...
Uncertainty fills the air. Will President Donald Trump's steep tariffs ignite a global trade war? Could the U.S. economy slip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback